NOT-HL-17-495: Notice of Intent to Publish a Funding Opportunity Announcement to Increase Use of Cardiac and Pulmonary Rehabilitation in Traditional and Community Settings (R61/R33)

Notice of Intent to Publish a Funding Opportunity Announcement to Increase Use of Cardiac and Pulmonary Rehabilitation in Traditional and Community Settings (R61/R33)

Notice Number: NOT-HL-17-495

Key Dates
Release Date: April 24, 2017

Estimated Publication Date of Announcement: July 2017
First Estimated Application Due Date: October 2017
Earliest Estimated Award Date: Summer/Fall 2018
Earliest Estimated Start Date: August 2018

Related Announcements
None

Issued by
National Heart, Lung, and Blood Institute (NHLBI)

Purpose

The National Heart, Lung, and Blood Institute intends to promote a new initiative by publishing a Funding Opportunity Announcement (FOA) to solicit applications for phase II clinical trials to test novel strategies for increasing participation in cardiac rehabilitation (CR) and pulmonary rehabilitation (PR) in adults after a qualifying event/condition.

This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and competitive research programs.

The FOA is expected to be published in Summer 2017 with an expected application due date in Fall 2017.

This FOA will utilize the R61/R33 activity code. Details of the planned FOA are provided below.

Research Initiative Details

This Notice encourages investigators with expertise in the areas of cardiac rehabilitation, pulmonary rehabilitation, and implementation science to consider applying for this FOA. Collaborative investigations combining expertise in telehealth, internet-based interventions, behavioral modification, and other novel techniques for health-related interventions will be encouraged.

The purpose of this initiative is to develop and test strategies to increase the utilization of CR and PR in eligible patients. The objectives are to test novel promising approaches to increase use of CR and PR overall, to reduce disparities in their utilization, and to document improvement in key clinical and patient-centered outcomes from CR and PR performed in either traditional or non-traditional settings.

APPLICATIONS ARE NOT BEING SOLICITED AT THIS TIME.

Inquiries

Please direct all inquiries to:

Division of Cardiovascular Sciences
Jerome Fleg, MD
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-435-0420
Email: flegj@nih.gov

Lawton Cooper, MD, MPH
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-435-0419
Email: cooperls@nih.gov

Center for Translation Research and Implementation Science
Susan Shero, RN, MS
National Heart, Lung and Blood Institute (NHLBI)
Telephone: 301-496-1051
Email: sheros@nih.gov

Division of Lung Diseases
Antonello Punturieri, MD, PhD
National Heart, Lung and Blood Institute (NHLBI)
Telephone: 301- 827-7844
Email: punturieria@nhlbi.nih.gov